Skip to content

Interest Income at other companies

MYR Group logo
MYR GroupMYRG
$910K+376%
Repligen logo
RepligenRGEN
$6.34M-13.3%
NNN REIT logo
NNN REITNNN
$28K-91.5%
Matsons logo
MatsonsMATX
$6.1M-35.1%
UBS
United BanksharesUBSI
$367.95M+4.6%
LQD
Liquidia CorporationLQDA
$1.77M+2.5%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's interest income?
Generate Biomedicines, Inc. (GENB) reported interest income of $2.91M in Q1 2026.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.